rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2003-5-20
|
pubmed:abstractText |
Chronic subtypes of depression appear to be associated with high rates of Axis II personality disorder comorbidity. Few studies, though, have systematically examined the clinical correlates of Axis II personality disorder comorbidity or its effect on treatment response or time to response.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0160-6689
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
554-61
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12755659-Adult,
pubmed-meshheading:12755659-Aged,
pubmed-meshheading:12755659-Antidepressive Agents, Tricyclic,
pubmed-meshheading:12755659-Chronic Disease,
pubmed-meshheading:12755659-Comorbidity,
pubmed-meshheading:12755659-Depressive Disorder,
pubmed-meshheading:12755659-Double-Blind Method,
pubmed-meshheading:12755659-Female,
pubmed-meshheading:12755659-Humans,
pubmed-meshheading:12755659-Imipramine,
pubmed-meshheading:12755659-Male,
pubmed-meshheading:12755659-Middle Aged,
pubmed-meshheading:12755659-Personality Disorders,
pubmed-meshheading:12755659-Psychiatric Status Rating Scales,
pubmed-meshheading:12755659-Quality of Life,
pubmed-meshheading:12755659-Serotonin Uptake Inhibitors,
pubmed-meshheading:12755659-Sertraline,
pubmed-meshheading:12755659-Survival Analysis,
pubmed-meshheading:12755659-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.
|
pubmed:affiliation |
Department of Psychiatry and Behavioral Sciences, The University of Texas Medical Branch at Galveston, 77555, USA. jrussell@utmb.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|